Cautiously Optimistic :: Aerpio Pharmaceuticals, Inc., (NASDAQ: ARPO)

 

On Monday, November 16, 2020, the Company, Aerpio Pharmaceuticals, Inc., ARPO stock construct a change of 10.12 percent (Gain) in a total of its share price and having its trading value $1.85, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $72.13M with the total Outstanding Shares of 42.14M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: ARPO):

 

Aerpio Pharmaceuticals, Inc. institutional ownership is standing at 27 percent, while insider ownership is 18.12 percent. As of now, ARPO has a P/S, P/E and, P/B values of 4.81, 0, and 1.65 respectively. Its P/Cash is valued at 1.52.

 

The stock SMA50 is now at 35.18 percent. In looking, the SMA 200 we see that the stock has seen a 73.55 percent. The Company?s net profit margin for the 12 months at -27 percent. Comparatively, the gazes have a Gross margin of 0 percent.


Profitability ratios:

 

Looking into the profitability ratios of ARPO stock, an investor will find its ROE, ROA, ROI standing at -10.1 percent, -9.4 percent and, 0 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 14.44 percent volatile for the week and 9.07 percent for the month.


Gross / Operating Margins of ARPO:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Aerpio Pharmaceuticals, Inc. recorded it at $2.


Historical Performance In The News:

 

Taking a look at the performance of Aerpio Pharmaceuticals, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 34.06 percent, resulting in a performance for the month at 36.03 percent.

Therefore, the stated figure displays a quarterly performance of 14.2 percent, bringing six-month performance to 140.26 percent and year to date performance of 196.71 percent. As of now, Aerpio Pharmaceuticals, Inc. has a P/S, P/E and, P/B values of 4.81, 0, and 1.65 respectively. Its P/Cash is valued at 1.52.


Earnings per Share Details of Aerpio Pharmaceuticals, Inc.:

 

The EPS of ARPO is strolling at -0.1, measuring its EPS growth this year at -87.1 percent. As a result, the company has an EPS growth of -320 percent for the approaching year.